Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:863-870
Published online before print February 28, 2008, doi: 10.1161/ATVBAHA.107.156687
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Additional Materials
Right arrow All Versions of this Article:
28/5/863    most recent
ATVBAHA.107.156687v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujita, K.
Right arrow Articles by Funahashi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujita, K.
Right arrow Articles by Funahashi, T.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:863.)
© 2008 American Heart Association, Inc.


Integrated Physiology/Experimental Medicine

Adiponectin Protects Against Angiotensin II–Induced Cardiac Fibrosis Through Activation of PPAR-{alpha}

Koichi Fujita; Norikazu Maeda; Mina Sonoda; Koji Ohashi; Toshiyuki Hibuse; Hitoshi Nishizawa; Makoto Nishida; Aki Hiuge; Akifumi Kurata; Shinji Kihara; Iichiro Shimomura; Tohru Funahashi

From the Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Japan.

Correspondence to Norikazu Maeda, MD, Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, 2-2-B5, Yamada-oka, Suita, Osaka 565-0871, Japan. E-mail nmaeda{at}imed2.med.osaka-u.ac.jp

Objectives— Adiponectin is recognized as an antidiabetic, antiatherosclerotic, and anti-inflammatory protein derived from adipocytes. However, the role of adiponectin in cardiac fibrosis remains uncertain. We herein explore the effects of adiponectin on cardiac fibrosis induced by angiotensin II (Ang II).

Methods and Results— Wild-type (WT), adiponectin knockout (Adipo-KO), and PPAR-{alpha} knockout (PPAR-{alpha}-KO) mice were infused with Ang II at 1.2 mg/kg/d. Severe cardiac fibrosis and left ventricular dysfunction were observed in Ang II–infused Adipo-KO mice compared to WT mice. Adenovirus-mediated adiponectin treatment improved the above phenotypes and the dysregulation of reactive oxygen species (ROS)-related mRNAs in Adipo-KO mice, whereas such amelioration was not observed in PPAR-{alpha}-KO mice despite adiponectin accumulation in heart tissue. In cultured cardiac fibroblasts, adiponectin improved the reduction of AMP-activated protein kinase (AMPK) activity and elevation of extracellular signal–regulated kinase 1/2 (ERK1/2) activity induced by Ang II. Adiponectin significantly enhanced PPAR-{alpha} activity, whereas the adiponectin-dependent PPAR-{alpha} activation was diminished by Compound C, an inhibitor of AMPK.

Conclusion— The present study suggests that adiponectin protects against Ang II–induced cardiac fibrosis possibly through AMPK-dependent PPAR-{alpha} activation.

Adiponectin-deficient mice revealed severe angiotensin II–induced cardiac fibrosis and its phenotype were reversed by adiponectin supplementation. However, adiponectin treatment failed to ameliorate cardiac fibrosis in angiotensin II–infused PPAR-{alpha}-deficient mice. In vivo and in vitro experiments suggested that adiponectin protects against angiotensin II–induced cardiac fibrosis possibly through AMPK-dependent PPAR-{alpha} activation.


Key Words: adiponectin • angiotensin II • PPAR-{alpha} • fibrosis • AMPK




This article has been cited by other articles:


Home page
Eur J Heart FailHome page
A. Kis, C. Murdoch, M. Zhang, A. Siva, S. Rodriguez-Cuenca, S. Carobbio, A. Lukasik, M. Blount, S. O'Rahilly, S. L. Gray, et al.
Defective peroxisomal proliferators activated receptor gamma activity due to dominant-negative mutation synergizes with hypertension to accelerate cardiac fibrosis in mice
Eur J Heart Fail, June 1, 2009; 11(6): 533 - 541.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. Krenning, J.-R. A.J. Moonen, and M. C. Harmsen
Pleiotropism of Adiponectin: Inflammation, Neovascularization, and Fibrosis
Circ. Res., May 8, 2009; 104(9): 1029 - 1031.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Huang, C. Yang, Y. Wang, Y. Liao, and K. Huang
PARP-1 suppresses adiponectin expression through poly(ADP-ribosyl)ation of PPAR{gamma} in cardiac fibroblasts
Cardiovasc Res, January 1, 2009; 81(1): 98 - 107.
[Abstract] [Full Text] [PDF]